Nutritional Problems After Lung and Heart Transplantation
NCT ID: NCT00826254
Last Updated: 2011-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
94 participants
INTERVENTIONAL
2003-08-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Part 2) Fat metabolism and endocrine parameters - possible predictors for developement of overweight after transplantation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Intervention Trial Targeting Metabolic Syndrome After Kidney Transplantation
NCT04698408
Cardiovascular Risk Factors After Renal Transplantation in Children and Adults
NCT01008306
Bone and Cardiovascular Disease After Kidney Transplant
NCT02751099
Incidence, Risk Factors and Outcomes of Diaphragm Dysfunction After Lung Transplantation
NCT04103996
Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients
NCT03958409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin K
180 micrograms vitamin K daily
Vitamin K
2 capsules daily 180 micrograms vitamin K daily or placebo
1 year
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Foundation for Health and Rehabilitation
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rikshospitalet HF
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liv Forli, Dr
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Liv Forli, Dr
Role: STUDY_DIRECTOR
Oslo University Hospital
Oystein Bjortuft, MD
Role: STUDY_CHAIR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rikshospitalet HF
Oslo, Oslo County, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006/4716 (Personvernombud)
Identifier Type: -
Identifier Source: secondary_id
S-03124 (REK)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.